Aducanumab: A Deep Dive into BIIB037 and its Impact This medication, initially known as BIIB037, constitutes a complex endeavor to address emerging Alzheimer's disease. Developed by Biogen, the treatment works by https://prestonbsoh484071.activoblog.com/51790589/text